Blocking cell death limits lung damage and inflammation from influenza.

Animals that receive an inhibitor of an antiviral cell-death response called necroptosis are less likely to die of influenza even at a late stage of infection. This has implications for the development of therapies for respiratory diseases.Inhibiting necroptosis protects lungs against influenza-mediated damage. [ABSTRACT FROM AUTHOR]